Press Release Hinduja Global Solutions Limited has informed the Exchange regarding a press release dated May 29, 2026, titled "HGS REPORTS RS. 4,857 CRORE REVENUE FOR FY2026". Hinduja Global Solutions Limited has informed the Exchange regarding a press release dated May 29, 2026, titled "HGS REPORTS RS. 4,857 CRORE REVENUE FOR FY2026".
Company Update In compliance to Regulation 30 of SEBI LODR, cessation of Shri Uttam Lal, Director (Personnel) of Company on attaining the age of superannuation w.e.f. 31.05.2026 (EoD) is submitted. In compliance to Regulation 30 of SEBI LODR, cessation of Shri Uttam Lal, Director (Personnel) of Company on attaining the age of superannuation w.e.f. 31.05.2026 (EoD) is submitted. In compliance to Regulation 30 of SEBI LODR, cessation of Shri Uttam Lal, Director (Personnel) of Company on attaini
Corp. Action Fixed Record Date of Dividend Fixed Record Date of Dividend Fixed Record Date of Dividend
Company Update In compliance to Regulation 30 of SEBI LODR, cessation of Shri Uttam Lal, Director (Personnel) of Company on attaining the age of superannuation w.e.f. 31.05.2026 (EoD) is submitted. In compliance to Regulation 30 of SEBI LODR, cessation of Shri Uttam Lal, Director (Personnel) of Company on attaining the age of superannuation w.e.f. 31.05.2026 (EoD) is submitted. In compliance to Regulation 30 of SEBI LODR, cessation of Shri Uttam Lal, Director (Personnel) of Company on attaini
Outcome of Board Meeting Mamata Machinery Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Mamata Machinery Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Mamata Machinery Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Mamata Machinery Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Analysts/Institutional Investor Meet/Con. Call Updates Natco Pharma Limited has informed the Exchange about Transcript 📞 Full concall summary follows in the next message(s) on Telegram. Natco Pharma Limited has informed the Exchange about Transcript Natco Pharma Limited has informed the Exchange about Transcript Natco Pharma Limited has informed the Exchange about Transcript
Investor Presentation Xelpmoc Design And Tech Limited has informed the Exchange about Investor Presentation Xelpmoc Design And Tech Limited has informed the Exchange about Investor Presentation
Investor Presentation Xelpmoc Design And Tech Limited has informed the Exchange about Investor Presentation Xelpmoc Design And Tech Limited has informed the Exchange about Investor Presentation
Result Simbhaoli Sugars Limited hereby submitted Consolidated Unaudited Financial Results for the Quarter ended 30th September, 2025 Simbhaoli Sugars Limited hereby submitted Consolidated Unaudited Financial Results for the Quarter ended 30th September, 2025
Result Simbhaoli Sugars Limited hereby submitted Consolidated Unaudited Financial Results for the Quarter ended 30th September, 2025 Simbhaoli Sugars Limited hereby submitted Consolidated Unaudited Financial Results for the Quarter ended 30th September, 2025
Company Update The record date for determining the members eligible to receive the dividend will be Wednesday 2nd September 2026 (Record Date) The dividend, if approved, will be paid to those shareholders whose name appears on the Register of Members maintained by the Company/ List of Beneficial Owners as received from the depositories as on 2nd September 2026 (Record date) The record date for determining the members eligible to receive the dividend will be Wednesday 2nd September 2026 (Re
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.